- Home
- MNDY vs NBIX Comparison
MNDY vs NBIX Comparison
Compare MNDY & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDY
- NBIX
- Stock Information
- Founded
- MNDY 2012
- NBIX 1992
- Country
- MNDY Israel
- NBIX United States
- Employees
- MNDY N/A
- NBIX N/A
- Industry
- MNDY Computer Software: Prepackaged Software
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNDY Technology
- NBIX Health Care
- Exchange
- MNDY Nasdaq
- NBIX Nasdaq
- Market Cap
- MNDY 9.5B
- NBIX 14.4B
- IPO Year
- MNDY 2021
- NBIX 1996
- Fundamental
- Price
- MNDY $160.68
- NBIX $144.77
- Analyst Decision
- MNDY Strong Buy
- NBIX Strong Buy
- Analyst Count
- MNDY 23
- NBIX 18
- Target Price
- MNDY $280.61
- NBIX $172.33
- AVG Volume (30 Days)
- MNDY 1.2M
- NBIX 1.1M
- Earning Date
- MNDY 11-10-2025
- NBIX 10-28-2025
- Dividend Yield
- MNDY N/A
- NBIX N/A
- EPS Growth
- MNDY 192.87
- NBIX 12.44
- EPS
- MNDY 1.23
- NBIX 4.19
- Revenue
- MNDY $1,166,095,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- MNDY $28.70
- NBIX $23.68
- Revenue Next Year
- MNDY $22.30
- NBIX $18.02
- P/E Ratio
- MNDY $131.01
- NBIX $35.03
- Revenue Growth
- MNDY 28.62
- NBIX 19.61
- 52 Week Low
- MNDY $151.00
- NBIX $84.23
- 52 Week High
- MNDY $342.64
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- MNDY 33.12
- NBIX 50.90
- Support Level
- MNDY $157.00
- NBIX $145.00
- Resistance Level
- MNDY $169.76
- NBIX $148.84
- Average True Range (ATR)
- MNDY 8.71
- NBIX 5.31
- MACD
- MNDY -3.96
- NBIX -0.33
- Stochastic Oscillator
- MNDY 16.63
- NBIX 47.17
About MNDY monday.com Ltd.
Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.